PRICE T ROWE ASSOCIATES INC /MD/

Position in LPCN — Lipocine Inc.

CIK 80255 BALTIMORE, MD

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,400

-$24,122 QoQ

Shares Held

12,266

+19.4% QoQ

Ownership

0.149%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 36 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. LPCN ranks #298 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,400	12,266	-93.0%	Shares	Defined	2026-08-14
2023-03-31	$55,522	174,600	-5.4%	Shares	Defined	2023-05-15
2022-12-31	$73,495	184,662	0.0%	Shares	Defined	2023-02-14
2022-09-30	$83,097	184,662	0.0%	Shares	Defined	2022-11-14
2022-06-30	$147,914	184,662	0.0%	Shares	Sole	2022-08-15
2022-03-31	$252,986	184,662	0.0%	Shares	Sole	2022-05-16
2021-12-31	$183,000	184,662	+2.7%	Shares	Sole	2022-02-14
2021-09-30	$196,051	179,864	+101.5%	Shares	Sole	2021-11-15
2021-06-30	$124,969	89,264	0.0%	Shares	Sole	2021-08-16
2021-03-31	$134,788	89,264	+238.6%	Shares	Sole	2021-05-17
2020-09-30	$37,173	26,364	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.